2rounds
—led
Enterprise software 1Healthtech 1
Series A 2
Loading investors…
Loading investors…
Ranked by rounds participated in, from announcements in Jan 1, 2026 – Oct 4, 2026. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Growth 1, Series B 1
Axelera AI $250M GrowthSage Geosystems $97M Series BNew companies 2 · Follow-on 0
Stages: Growth 1, Undisclosed 1
Subject $28M GrowthKore.ai Undisclosed Strategic GrowthNew companies 2 · Follow-on 0
Stages: Seed 1, Series C+ 1
Ubicquia $106M Series DPluto Financial Technologies $8.6M SeedNew companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Yendo $200M UndisclosedAscent $45M Series CNew companies 2 · Follow-on 0
Stages: Undisclosed 2
Ten63 Therapeutics $45M StrategicMorpheus Space $15M StrategicNew companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Ownwell $50M Series BThe Biological Computing $25M SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Korsana Biosciences $175M Series AMirador Therapeutics $250M Series BNew companies 2 · Follow-on 0
Stages: Growth 1, Series A 1
Circuit $30M GrowthAres Interactive $70M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Selector $32M Series BRainfall Health $15M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Aliro $15M Series BNeurophos $110M Series ANew companies 2 · Follow-on 0
Stages: Pre-seed 1, Undisclosed 1
ScyAI €2M Pre-SeedArctis AI $1M UndisclosedNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Trust & Will Undisclosed StrategicAccrual $75M Series ANew companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Anterior $40M UndisclosedMews $300M Series DNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Electric Twin $14M Series AMozart AI $6M SeedNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
The Biological Computing $25M SeedSomethings $19.2M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Brandlight $30M Series ABiographica £7M UndisclosedNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Neurent Medical €62.5M Series CExciva €51M Series B“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.